• 1
  • 2
  • 3
$75
Help give more women access to molecular profiling.
$175
Support education that helps women and doctors identify gynaecological cancer earlier.
$450
Help fund more clinical trials of potentially life-saving treatments.
$

Your Details

Help raise $50,000 by December 31 to fund life-saving treatment

$275 raised

$50,000 Goal

$275 raised

$50,000 Goal

Amount raised

  • Kristina just donated $10.00
  • Tim just donated $28.81
  • Chris just donated $366.00
  • Tracey just donated $100.00
  • Regina just donated $168.72
  • cathy just donated $6.20
  • Philippa just donated $108.30
  • Carolyn just donated $82.13
  • John just donated $55.95
  • Lucy just donated $55.95
  • Ashley just donated $23.81
  • Lindy just donated $55.95
  • Jane just donated $55.95
  • Sheryl just donated $82.13
  • Amy just donated $516.00
  • Steve just donated $106.75
  • Deborah just donated $106.75
  • Maychelle just donated $54.75
  • Yvonne just donated $28.81
  • Tilani and Family Thenabadu just donated $28.81

It should have been ‘just another Christmas.’

Jo was the big sister – the looker-after who was there for everyone.

She was determined and passionate. When she loved something or someone, she loved hard - like the TV show Countdown, her family, and the environment.

Christmas 2022 was the start of it. When they gathered for family celebrations, Jo wasn’t her usual self. It took a lot of tests and appointments for Jo to learn she had high-grade, serous ovarian cancer.

Surgery and chemo knocked her about. But she kept going, looking after grandkids and doing her bit for the environment. As soon as she could, she went back to her job that she loved as a mental health nurse.

Jo had responded well to treatment, but she felt something wasn’t right. She asked for a scan the following December. The results came back in January. Her cancer had spread to her liver and was inoperable.

Jo’s hopes rose when she was accepted for several clinical trials, but between administrative and eligibility issues, Jo never made it through. Genevra and Jacinta can’t help thinking that these were lost opportunities.

Jo’s passing has devastated her family. But they are determined to keep her memory alive. Now they are sharing her story to continue her generous legacy and hope that one day, another family won't have to go through what they did. 

This Christmas, a donation to ANZGOG | WomenCan can
help give women like Jo a better chance of surviving ovarian cancer.

Please donate generously this Christmas. Jo would love that.

We’re losing too many women to ovarian cancer.

Every day in Australia, 5 women are diagnosed with ovarian cancer.

3 women die from ovarian cancer every day.



Only 1 in 2 women with ovarian cancer are alive five years after diagnosis.


Please help give women a better chance of surviving ovarian cancer. Donate to ANZGOG | WomenCan today.

We won't stop until every woman has access to the best possible cancer treatments.

At ANZGOG | WomenCan we’re committed to pushing cutting-edge gynaecological cancer research forward.

But breakthroughs can only save lives if every woman has access to them. 

That is the potential of Molecular Profiling.

Molecular profiling works by extracting DNA strands from a tumour sample, creating a detailed understanding of a woman’s unique cancer.

This helps doctors propose more targeted treatments and care. More importantly, it can easily tell doctors if a woman qualifies for a clinical trial – where she could access the latest life-extending treatments.

This all means fewer harsh treatments and needless side effects and more lives saved.

"We know molecular profiling and access to clinical trials can significantly extend and improve lives. We must accelerate this progress to ensure no woman is left behind."

Professor Clare Scott AM, MBBS PhD FRACP FAHMS GAICD, Chair, Australia New Zealand Gynaecological Oncology Group (ANZGOG)

But today, more than 90% of women with gynaecological cancers will miss out on comprehensive molecular profiling. That means they also miss out on the chance to access the best treatments currently available.

With limited government funding and high costs, so many Australian women are still missing out on the treatments which could save their lives.

You have the power to change that. By donathing today, you'll fund the vital work needed to make early molecular profiling a standard of care in Australia.

Help women access treatments that could extend their lives, so we don’t lose more of our mothers, daughters or sisters to ovarian cancer.

"I'm so grateful to be on this trial that have kept the cancer stable. I've been feeling great and have been living a relatively 'normal' life doing the things I enjoy with the people I love."


Alex

"I stay positive by holding out hope for new treatments that can keep me alive longer, I’ve had years longer than doctors expected."



Alisha

"I had this ticking time bomb in my pelvis, meanwhile, my children were still so young. I was determined to fight for more time with them"



Ali